E&E News, 4/13: Antonia Sepulveda, MD, chair of the Department of Pathology, was quoted in the article, "Supply runs low for COVID-19 testing compound."
As labs rush to tackle the backlog of coronavirus tests, a special chemical needed to determine whether a person has contracted the virus is running out.
Experts are concerned with the dwindling supply of RNA extraction reagents, causing labs to make tough decisions about which SARS-CoV-2 — the cause of COVID-19 — tests get processed. Read Full Article
